2024 Q3 Form 10-Q Financial Statement

#000109690624001722 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin $195.0K
YoY Change -26.34%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization -$7.610K
YoY Change -128.85%
% of Gross Profit
Operating Expenses $92.65K $145.0K $191.7K
YoY Change -61.21% -7.18% -34.15%
Operating Profit -$92.65K -$145.0K -$191.7K
YoY Change -61.21% -7.18% -33.65%
Interest Expense $3.238K $599.00 $320.00
YoY Change -78.84% -96.53% -101.55%
% of Operating Profit
Other Income/Expense, Net -$3.238K $34.40K -$203.0K
YoY Change -100.33% 9003.59%
Pretax Income -$394.4K
YoY Change -53.95%
Income Tax $399.00 $980.00
% Of Pretax Income
Net Earnings -$95.89K -$111.0K -$395.3K
YoY Change -113.06% -36.03% -53.84%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 123.5M shares 123.5M shares 123.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $290.4K
YoY Change -8.05%
Cash & Equivalents $5.311K $15.17K $290.4K
Short-Term Investments
Other Short-Term Assets $4.390K $4.133K $4.855K
YoY Change -63.45% 7.55% 199.14%
Inventory
Prepaid Expenses $29.68K $17.64K $24.62K
Receivables $4.860K
Other Receivables $0.00
Total Short-Term Assets $39.38K $36.94K $319.9K
YoY Change -94.24% -32.8% -6.49%
LONG-TERM ASSETS
Property, Plant & Equipment $501.3K $506.3K $516.3K
YoY Change -3.6% -57.02% -57.29%
Goodwill $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $557.4K $566.4K $584.2K
YoY Change -5.79% -54.81% -54.78%
TOTAL ASSETS
Total Short-Term Assets $39.38K $36.94K $319.9K
Total Long-Term Assets $557.4K $566.4K $584.2K
Total Assets $596.8K $603.3K $904.1K
YoY Change -53.22% -53.89% -44.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $200.2K $176.8K $183.6K
YoY Change 35.62% 17.01% -3.27%
Accrued Expenses $88.15K $77.34K $64.78K
YoY Change 39.14% 50.59% 53.48%
Deferred Revenue
YoY Change
Short-Term Debt $136.7K
YoY Change -80.75%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $685.0K $595.8K $648.8K
YoY Change 4.73% -58.77% -55.69%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $685.0K $595.8K $648.8K
Total Long-Term Liabilities $0.00
Total Liabilities $685.0K $595.8K $648.8K
YoY Change 4.73% -58.77% -55.69%
SHAREHOLDERS EQUITY
Retained Earnings -$84.77M -$84.67M -$84.39M
YoY Change 0.92% -0.07% 0.04%
Common Stock $125.4K $125.4K $123.5K
YoY Change 1.58% 1.58% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$88.23K $7.517K $255.3K
YoY Change
Total Liabilities & Shareholders Equity $596.8K $603.3K $904.1K
YoY Change -53.22% -53.89% -44.67%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q4
OPERATING ACTIVITIES
Net Income -$95.89K -$111.0K -$395.3K
YoY Change -113.06% -36.03% -53.84%
Depreciation, Depletion And Amortization -$7.610K
YoY Change -128.85%
Cash From Operating Activities -$344.1K
YoY Change 90.87%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.070K
YoY Change
Cash From Investing Activities $1.070K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -17.98K
YoY Change -55.03%
NET CHANGE
Cash From Operating Activities -344.1K
Cash From Investing Activities 1.070K
Cash From Financing Activities -17.98K
Net Change In Cash -361.0K
YoY Change 63.9%
FREE CASH FLOW
Cash From Operating Activities -$344.1K
Capital Expenditures $0.00
Free Cash Flow -$344.1K
YoY Change 90.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84674168 usd
CY2024Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
34883 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
36183 usd
CY2023Q4 weed Notes Payable Related Parties Classified Current Gross
NotesPayableRelatedPartiesClassifiedCurrentGross
157000 usd
CY2024Q2 weed Loan Fee Net Of Amortization
LoanFeeNetOfAmortization
18800 usd
CY2023Q4 weed Loan Fee Net Of Amortization
LoanFeeNetOfAmortization
23927 usd
CY2024Q2 weed Notes Payable Related Parties Classified Current1
NotesPayableRelatedPartiesClassifiedCurrent1
123200 usd
CY2023Q4 weed Notes Payable Related Parties Classified Current1
NotesPayableRelatedPartiesClassifiedCurrent1
133073 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001393772
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123482685 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123482685 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-219922
dei Entity Registrant Name
EntityRegistrantName
WEED, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-0452269
dei Entity Address Address Line1
EntityAddressAddressLine1
4920 N. Post Trail
dei Entity Address City Or Town
EntityAddressCityOrTown
Tucson
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85750
dei City Area Code
CityAreaCode
520
dei Local Phone Number
LocalPhoneNumber
818-8582
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
123482685 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15171 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
290409 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17635 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
24622 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4133 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4855 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
36939 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
319886 usd
CY2024Q2 us-gaap Land
Land
258319 usd
CY2023Q4 us-gaap Land
Land
258319 usd
CY2024Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
218681 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
218681 usd
CY2024Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
147771 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
147771 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
624771 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
624771 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
118474 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
108431 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
506297 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
516340 usd
CY2024Q2 weed Finite Lived License
FiniteLivedLicense
667 usd
CY2023Q4 weed Finite Lived License
FiniteLivedLicense
667 usd
CY2024Q2 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
50000 usd
CY2023Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
50000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
50667 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
50667 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15784 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14484 usd
CY2024Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
34883 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
36183 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25177 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
31653 usd
CY2024Q2 us-gaap Assets
Assets
603296 usd
CY2023Q4 us-gaap Assets
Assets
904062 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
176776 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
183565 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
77344 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
64778 usd
CY2024Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
139500 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
182500 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
13598 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
13000 usd
CY2024Q2 weed Notes Payable Related Parties Classified Current1
NotesPayableRelatedPartiesClassifiedCurrent1
123200 usd
CY2023Q4 weed Notes Payable Related Parties Classified Current1
NotesPayableRelatedPartiesClassifiedCurrent1
133073 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
3661 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
3661 usd
CY2024Q2 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
35800 usd
CY2023Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
35800 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
25177 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
31653 usd
CY2024Q2 weed Due To Officers Or Stockholders Current1
DueToOfficersOrStockholdersCurrent1
723 usd
CY2023Q4 weed Due To Officers Or Stockholders Current1
DueToOfficersOrStockholdersCurrent1
723 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
595779 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
648753 usd
CY2024Q2 us-gaap Liabilities
Liabilities
595779 usd
CY2023Q4 us-gaap Liabilities
Liabilities
648753 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123482685 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
125433 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
123483 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
84166001 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
83818351 usd
CY2024Q2 weed Subscription Payable
SubscriptionPayable
386250 usd
CY2023Q4 weed Subscription Payable
SubscriptionPayable
701250 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84674168 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84392563 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
4001 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
4788 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
7517 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
255309 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
603296 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
904062 usd
CY2024Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
85296 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
108730 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
221861 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
242512 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
51474 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
24077 usd
us-gaap Professional Fees
ProfessionalFees
76677 usd
us-gaap Professional Fees
ProfessionalFees
50173 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8185 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
23356 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16470 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
47386 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
144955 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
156163 usd
us-gaap Operating Expenses
OperatingExpenses
315008 usd
us-gaap Operating Expenses
OperatingExpenses
340071 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-144955 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-156163 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-315008 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-340071 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
599 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
17280 usd
us-gaap Interest Expense
InterestExpense
1198 usd
us-gaap Interest Expense
InterestExpense
30386 usd
CY2024Q2 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
35000 usd
CY2023Q2 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
0 usd
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
35000 usd
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
0 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34401 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33802 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
399 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
399 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-110953 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-173443 usd
us-gaap Profit Loss
ProfitLoss
-281605 usd
us-gaap Profit Loss
ProfitLoss
-370458 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-804 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2733 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-787 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2620 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-111757 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-170710 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-281992 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-367838 usd
CY2024Q2 weed Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
126270894 shares
CY2023Q2 weed Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
123482685 shares
weed Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
125176789 shares
weed Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
123482685 shares
CY2024Q2 weed Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.001
CY2023Q2 weed Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.001
weed Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.002
weed Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.003
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
169796 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500 usd
CY2023Q1 weed Imputed Interest On Rp Loans
ImputedInterestOnRpLoans
5942 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-197014 usd
CY2023Q1 weed Other Comprehensive Income Net
OtherComprehensiveIncomeNet
-113 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1111 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500 usd
CY2023Q2 weed Imputed Interest On Rp Loans
ImputedInterestOnRpLoans
10444 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-197014 usd
CY2023Q2 weed Other Comprehensive Income Net
OtherComprehensiveIncomeNet
-113 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-136655 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500 usd
CY2023Q3 weed Imputed Interest On Rp Loans
ImputedInterestOnRpLoans
300 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
734248 usd
CY2023Q3 weed Other Comprehensive Income Net
OtherComprehensiveIncomeNet
1364 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
621757 usd
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500 usd
CY2023Q4 weed Imputed Interest On Rp Loans
ImputedInterestOnRpLoans
4808 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-395348 usd
CY2023Q4 weed Other Comprehensive Income Net
OtherComprehensiveIncomeNet
1592 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
255309 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500 usd
CY2024Q1 weed Imputed Interest On Rp Loans
ImputedInterestOnRpLoans
300 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-170652 usd
CY2024Q1 weed Other Comprehensive Income Net
OtherComprehensiveIncomeNet
17 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
107474 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2024Q2 weed Commonstock Issued For Services Amount
CommonstockIssuedForServicesAmount
11500 usd
CY2024Q2 weed Imputed Interest On Rp Loans
ImputedInterestOnRpLoans
300 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-110953 usd
CY2024Q2 weed Other Comprehensive Income Net
OtherComprehensiveIncomeNet
-804 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
7517 usd
weed Profit And Loss
ProfitAndLoss
281605 usd
weed Profit And Loss
ProfitAndLoss
370458 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
11343 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
47386 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5127 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4293 usd
weed Imputed Interest On Rp Loans
ImputedInterestOnRpLoans
600 usd
weed Imputed Interest On Rp Loans
ImputedInterestOnRpLoans
16386 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
14000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
45000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7709 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3750 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6789 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-38696 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-29836 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9341 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-259451 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-282998 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 usd
weed Repayments On Notes Payable Related Party
RepaymentsOnNotesPayableRelatedParty
0 usd
weed Repayments On Notes Payable Related Party
RepaymentsOnNotesPayableRelatedParty
-50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-42979 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-274451 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-285977 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
787 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2620 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
290409 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
315826 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15171 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32469 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
399 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
13598 usd
us-gaap Interest Paid Net
InterestPaidNet
5113 usd
CY2024Q2 weed Notes Payable Related Parties Classified Current Gross
NotesPayableRelatedPartiesClassifiedCurrentGross
142000 usd

Files In Submission

Name View Source Status
0001096906-24-001722-index-headers.html Edgar Link pending
0001096906-24-001722-index.html Edgar Link pending
0001096906-24-001722.txt Edgar Link pending
0001096906-24-001722-xbrl.zip Edgar Link pending
budz_10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
weed-20240630_cal.xml Edgar Link unprocessable
budz_ex311.htm Edgar Link pending
budz_ex312.htm Edgar Link pending
budz_ex321.htm Edgar Link pending
budz_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
budz_10q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
weed-20240630.xsd Edgar Link pending
weed-20240630_def.xml Edgar Link unprocessable
weed-20240630_lab.xml Edgar Link unprocessable
weed-20240630_pre.xml Edgar Link unprocessable